Pfizer (PFE) Surpasses Q3 Earnings and Revenue Estimates

What happened: Pfizer (PFE) reported quarterly adjusted earnings of $0.87 per share and revenue of $16.58 billion, beating the Zacks Consensus Estimate on both measures. Key numbers: EPS $0.87 vs. $0.72 estimate, a +20.83% surprise and flat versus $0.87 a year ago. Revenue $16.58 billion vs. $16.65 billion a year ago, a 2.80% estimate beat. Why it matters: The stock carries a Zacks Rank #3 (Hold), so shares are expected to perform in line with the market near term. Pfizer has topped consensus EPS and revenue estimates in each of the last four quarters. Market: -0.9% today ($21.02), +5.8% YTD — as of 13:45 UTC Coverage: 4 outlets in 24h

Pfizer (PFE) reported quarterly adjusted earnings of $0.87 per share and revenue of $16.58 billion, beating the Zacks Consensus Estimate on both measures.

The stock carries a Zacks Rank #3 (Hold), so shares are expected to perform in line with the market near term. Pfizer has topped consensus EPS and revenue estimates in each of the last four quarters. Market: -0.9% today ($21.02), +5.8% YTD — as of 13:45 UTC